Tender Details

Country: USA
Summary: Dod Duchenne Muscular Dystrophy, Clinical/Translational Research Award
UST Ref No: 118543467
Deadline: 08 Aug 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: USD 8560000
Notice Type: Tender
Document Ref. No.: HT942525DMDRPCTRA
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Summary: The Fiscal Year 2025 (Fy25) Duchenne Muscular Dystrophy Research Program (Dmdrp) Clinical/Translational Research Award (Ctra) Mechanism Supports Advanced Translational Research That Will Accelerate The Movement Of Promising Ideas In Duchenne Muscular Dystrophy (Dmd) Research Into Clinical Applications. Research Must Address At Least One Of The Fy25 Ctra Focus Areas. Research Projects Investigating Therapies That Will Be Efficacious Across The Life Span, Including Infants, Toddlers, And Nonambulatory Individuals, Are Strongly Encouraged.Distinctive Features: Applications Must Include Preliminary And/Or Published Data Relevant To Dmd To Support The Proposed Research Project. Pilot, Proof-Of-Principle Clinical Trials, And Correlative Studies To Better Inform Development Of Drugs, Devices, And Other Interventions Are Allowed. The Ctra Offers Two Funding Levels: Funding Level 1 To Support Smaller, Less Complex Preclinical And/Or Clinical Research; And Funding Level 2 To Support Larger, More Complex Preclinical And/Or Clinical Research.Early-Career Partnering Pi Option (Ppio): The Partnering Pi Must Be An Independent, Early-Career Investigator Within 10 Years Of Their First Faculty Appointment (Or Equivalent) By The Time Of Application Submission. Lapses In Research Time Or Appointments As Denoted In The Biographical Sketch Should Be Explained In The Application.It Is Encouraged, But Not Required, That The Partnering Pi Is An M.D. Or M.D./Ph.D. To Increase Collaboration Be...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Dod Duchenne Muscular Dystrophy, Clinical/Translational Research Award - USA Tender

The DEPT. OF THE ARMY -- USAMRAA, a Government sector organization in USA, has announced a new tender for Dod Duchenne Muscular Dystrophy, Clinical/Translational Research Award. This tender is published on USARFP under UST Ref No: 118543467 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-08.

The estimated tender value is USD 8560000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.